Sunday, May 08, 2022 4:02:27 PM
Purchase obligation / commitment has two parts:
a.) Certain of the agreements with the suppliers include minimum purchase obligations. These purchases are generally made on the basis of rolling 12-month forecasts which in part are binding on Amarin and the balance of which are subject to adjustment by Amarin subject to certain limitations.
b.) Certain of the agreements also include contractual minimum purchase commitments regardless of the rolling 12-month forecasts.
Inventory cash-flow equal with (-) COGS (+/-) change of inventory. Amarin had the following
Period: COGS / Inventory* / Change in inventory = Cash-flow / Commitment at the end of the period** / Change in commitment.
* They have a “new” inventory category since end of 2021 (long-term inventory: when consumption of the inventory is expected normal operating cycle) but as I do not know the duration of the normal operating cycle I did not separate it in this analysis … just as a note below.)
** Pursuant to the supply agreements, there is a total of approximately $ X million that is potentially payable over the term of such agreements based on minimum purchase obligations.
2020: 131* / 189* / 112** = 244* / 326* / +134**
2021 Q1: 28 / 231 / 42 = 70 / 213 / -113
2021 Q2: 32 / 272 / 42 = 74 / 213 / 0
2021 Q3: 30 / 309 / 37 = 67 / 213 / 0
2021 Q4: 31 / 356 / 47 = 77 / 196 / -17
2021: 121* / 356* / 167** = 288* / 196* / -130**
2022 Q1: 22 / 409 / 53 = 75 / 49 / -147
* Sum of the year or at the end of the year
** vs. previous year end
So what could be changed?
First of all: it was an awful “goods” / inventory management e.g. (i) they spent more in 2021 than in 2020 (ii) commitment was not changed during Q2 & Q3 2021 …
The good things (looks like as … based on these data): they are managing the inventory since August 1 (?), 2021 … since Q4 2021 (i) separating the short-term and long-term inventory (ii) reducing obligation / commitment.
The commitment is ATL (49) as of March 31, 2021 and I assume that it is “100”% the contractual minimum purchase commitments (regardless of the rolling 12-month forecasts) or contains minimal rolling 12-month forecasts.
I will use the following assumptions:
(i) the 49 commitment is due till the end of 2022 (I think it is conservative)
(ii) they will not purchase anything top of the commitment (Maybe it is a bold assumption … but it is a prudent one).
What it means?
API purchase was -75 (75% of total net CF) in Q1. This and the 49 commitment means -124 spending on API in 2022 (vs 244 and 288 in 2020 and 2021 respectively).
- They had 389 cash as of March 31, 2022.
- The non-API related net cash-flow was -24 in Q1 2022
- Assuming – but it is not the case – revenue and other cost / cash-flow will be flat (“same” as in Q1) they will have 317 cash as of December 31, 2022.
Note:
(i) I would like to analyze the API / inventory only (independently from other elements).
(ii) I did not analyzed the long-term inventory separately – two data available only – but it will be “interesting” to check the level of it (EOY2021: 121; EOQ12022: 141). As the short term level is 268 I expect an increase in the upcoming quarters – meanwhile the short-term decreasing – but a decrease after a certain quarters.
Best,
G
Disclosure: I wrote this post myself, and it expresses my own opinions (IMHO). I am not receiving compensation for it.
Notice: This post is not investment advice, and not a recommendation to neither buy nor hold nor sell.
Recent AMRN News
- Amarin to Present at H.C. Wainwright 2nd Annual BioConnect Investor Conference • GlobeNewswire Inc. • 05/06/2024 12:00:00 PM
- Amarin Reports First Quarter 2024 Business Update and Financial Results • GlobeNewswire Inc. • 05/01/2024 11:00:00 AM
- Amarin Applauds HealthyWomen’s Citizen’s Petition Urging FDA To Take Further Action On Fenofibrate Prescribing in Patients at Risk of Cardiovascular Event • GlobeNewswire Inc. • 04/24/2024 06:00:01 PM
- Amarin Announces Results of Annual General Meeting of Shareholders • GlobeNewswire Inc. • 04/22/2024 12:00:25 PM
- Amarin to Report First Quarter 2024 Financial Results and Host Conference Call on May 1, 2024 • GlobeNewswire Inc. • 04/15/2024 12:00:00 PM
- Amarin Highlights Key Data Providing Mechanistic Insights into Eicosapentaenoic Acid (EPA) at ACC.24 • GlobeNewswire Inc. • 04/08/2024 12:00:00 PM
- New REDUCE-IT® Analyses Show VASCEPA® (Icosapent Ethyl) Benefit in High-Risk Cardiovascular Disease Patient Subgroups • PR Newswire (Canada) • 04/08/2024 10:30:00 AM
- New REDUCE-IT® Analyses Show VASCEPA®/VAZKEPA® (Icosapent Ethyl) Benefit in High-Risk Cardiovascular Disease Patient Subgroups • GlobeNewswire Inc. • 04/06/2024 07:30:00 PM
- Amarin Provides Update on VAZKEPA® (Icosapent Ethyl) Intellectual Property Portfolio in Europe • GlobeNewswire Inc. • 04/03/2024 12:00:00 PM
- Research Evaluating Benefits of VASCEPA®/VAZKEPA® (icosapent ethyl) to be Presented at the American College of Cardiology’s (ACC) Annual Scientific Session & Expo • GlobeNewswire Inc. • 03/25/2024 12:00:00 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 03/04/2024 10:30:53 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 03/04/2024 01:00:24 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/29/2024 12:06:26 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/29/2024 12:05:56 PM
- Amarin Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update • GlobeNewswire Inc. • 02/29/2024 12:00:00 PM
- Amarin to Report Fourth Quarter and Full Year 2023 Financial Results and Host Conference on February 29, 2024 • GlobeNewswire Inc. • 02/15/2024 01:00:00 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 02/12/2024 01:00:24 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/09/2024 09:31:50 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/09/2024 09:30:28 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/09/2024 09:30:12 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/02/2024 09:30:24 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/02/2024 09:30:22 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/02/2024 09:30:11 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/26/2024 12:00:49 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/24/2024 09:31:21 PM
Branded Legacy, Inc. Unveils Collaboration with Celebrity Tattoo Artist Kat Tat for New Tattoo Aftercare Product • BLEG • May 22, 2024 8:30 AM
"Defo's Morning Briefing" Set to Debut for "GreenliteTV" • GRNL • May 21, 2024 2:28 PM
North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM
VPR Brands (VPRB) Reports First Quarter 2024 Financial Results • VPRB • May 17, 2024 8:04 AM